Limitations in qualitative point of care hCG tests for detecting early pregnancy

Clinica Chimica Acta

Volumn 415, Issue , 2013, Pages 317-321

  Greene, Dina N ^a   Schmidt, Robert L ^b   Kamer, Sandy M ^a   Grenache, David G ^b   Hoke, Carolyn ^a   Lorey, Thomas S ^a  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

False negative; HCG; Point of care; Pregnancy detection; Serum; Urine

Indexed keywords

CHORIONIC GONADOTROPIN;

ARTICLE; BLOOD SAMPLING; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HORMONE URINE LEVEL; HUMAN; LABORATORY DEVICE; MAJOR CLINICAL STUDY; POINT OF CARE TESTING; PREGNANCY TEST; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; URINALYSIS;

CHORIONIC GONADOTROPIN; FALSE NEGATIVE REACTIONS; FEMALE; GESTATIONAL AGE; HUMANS; LIMIT OF DETECTION; POINT-OF-CARE SYSTEMS; PREGNANCY; PREGNANCY TESTS; PROBABILITY; REFERENCE VALUES;

EID: 84875072232     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.10.053     Document Type: Article

References (13)

1. Furtado L.V., Lehman C.M., Thompson C., Grenache D.G. Should the qualitative serum pregnancy test be considered obsolete?. Am J Clin Pathol 2012, 137:194-202.
2. Lazarenko G.C., Dobson C., Enokson R., Brant R. Accuracy and speed of urine pregnancy tests done in the emergency department: a prospective study. CJEM 2001, 3:292-295.
3. OSOM package insert.
4. QuickVue+ package insert.
5. Cervinski M.A., Lockwood C.M., Ferguson A.M., et al. Qualitative point-of-care and over-the-counter urine hCG devices differentially detect the hCG variants of early pregnancy. Clin Chim Acta 2009, 406:81-85.
6. Sigel C.S., Grenache D.G. Detection of unexpected isoforms of human chorionic gonadotropin by qualitative tests. Clin Chem 2007, 53:989-990.
7. de Medeiros S.F., Norman R.J. Human choriogonadotrophin protein core and sugar branches heterogeneity: basic and clinical insights. Hum Reprod Update 2009, 15:69-95.
8. Whittington J., Fantz C.R., Gronowski A.M., et al. The analytical specificity of human chorionic gonadotropin assays determined using WHO International Reference Reagents. Clin Chim Acta 2010, 411:81-85.
9. Seimens Diagnostics P. hCG assay Immulite package insert.
10. Lempiainen A., Hotakainen K., Alfthan H., Stenman U.H. Loss of human chorionic gonadotropin in urine during storage at -20 degrees C. Clin Chim Acta 2012, 413:232-236.
11. Grenache D.G., Greene D.N., Dighe A.S., et al. Falsely decreased human chorionic gonadotropin (hCG) results due to increased concentrations of the free beta subunit and the beta core fragment in quantitative hCG assays. Clin Chem 2010, 56:1839-1844.
12. Gronowski A.M., Cervinski M., Stenman U.H., Woodworth A., Ashby L., Scott M.G. False-negative results in point-of-care qualitative human chorionic gonadotropin (hCG) devices due to excess hCGbeta core fragment. Clin Chem 2009, 55:1389-1394.
13. Gronowski A.M., Powers M., Stenman U.H., Ashby L., Scott M.G. False-negative results from point-of-care qualitative human chorionic gonadotropin (hCG) devices caused by excess hCGbeta core fragment vary with device lot number. Clin Chem 2009, 55:1885-1886.